News & Updates

Stay informed with the latest press releases and updates from NeuPath Health Inc., including announcements, milestones, and insights shaping our journey.

Featured

April 15, 2025

NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH

2025

April 15, 2025

NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH

March 27, 2025

NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT

March 27, 2025

NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS

March 6, 2025

NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID®, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS

2024

December 10, 2024

NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS

November 27, 2024

NEUPATH HEALTH ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID

November 14, 2024

NEUPATH HEALTH REPORTS THIRD QUARTER 2024 RESULTS

October 21, 2024

NEUPATH HEALTH TO BE FEATURED ON RADIUS RESEARCH’S PITCH, DEEP DIVE AND Q&A WEBINAR

August 15, 2024

NEUPATH HEALTH REPORTS SECOND QUARTER 2024 Results

June 13, 2024

NeuPath Health Announces Voting Results From the Annual General and Special Meeting of Shareholders

May 16, 2024

NEUPATH HEALTH REPORTS RECORD QUARTERLY REVENUES WITH FIRST QUARTER 2024 RESULTS

April 10, 2024

NEUPATH HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

April 4, 2024

NEUPATH ANNOUNCES CLINIC ACQUISITION

March 15, 2024

NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2023 RESULTS

2023

November 16, 2023

NEUPATH HEALTH REPORTS THIRD QUARTER 2023 RESULTS

November 13, 2023

NEUPATH HEALTH ANNOUNCES SUCCESSFUL CLOSING OF UPDATED CREDIT FACILITY

September 6, 2023

NEUPATH SUCCESSFULLY COMPLETES SALE OF CORPORATE-OWNED MEDICAL FACILITY

August 17, 2023

NEUPATH HEALTH DELIVERS RECORD QUARTERLY REVENUES

June 15, 2023

NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS

May 25, 2023

NEUPATH HEALTH DELIVERS STRONG QUARTERLY REVENUES AND IMPROVES CASH POSITION

May 15, 2023

NEUPATH ANNOUNCES THE POSITIVE RESOLUTION OF ITS OUTSTANDING HST MATTER WITH THE CRA

May 2, 2023

NEUPATH HEALTH ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BROKERED OFFERING OF $1.453 MILLION OF SUBORDINATED AND POSTPONED UNSECURED NON-CONVERTIBLE DEBENTURES

April 18, 2023

NEUPATH HEALTH TO PRESENT AT THE 2023 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

April 11, 2023

NEUPATH HEALTH ANNOUNCES PROPOSED BROKERED OFFERING OF SUBORDINATED AND POSTPONED UNSECURED NON-CONVERTIBLE DEBENTURES OF UP TO $1.4 MILLION

March 30, 2023

NEUPATH HEALTH DELIVERS RECORD QUARTERLY REVENUES AND OPENS NEW FLUOROSCOPY SUITE TO PATIENTS

March 21, 2023

NEUPATH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FISCAL 2022

March 15, 2023

NEUPATH SELLS CORPORATE-OWNED MEDICAL FACILITY

March 9, 2023

NEUPATH CEO LETTER TO SHAREHOLDERS

2022

November 17, 2022

NEUPATH HEALTH DELIVERS STRONG QUARTERLY REVENUES AND OPENS NEW FLUOROSCOPY SUITE TO PATIENTS

October 19, 2022

NEUPATH HEALTH ANNOUNCES UPDATES TO THE BOARD OF DIRECTORS

September 30, 2022

NEUPATH PROVIDES STRATEGIC UPDATE, ANNOUNCES BOARD AND EXECUTIVE CHANGES

August 26, 2022

NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS

August 18, 2022

NEUPATH HEALTH DELIVERS RECORD QUARTERLY REVENUES AND ADJUSTED EBITDA GROWTH QUARTER-OVER-QUARTER

TORONTO, ONTARIO, August 18, 2022 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial […]

August 9, 2022